Related Experiment Videos
Ultrasound contrast for hepatic tumors using IDE particles
K J Parker1, R B Baggs, R M Lerner
1Department of Electrical Engineering, University of Rochester, New York 14627.
Investigative Radiology
|October 1, 1990
Summary
Iodipimide ethyl ester (IDE) particles enhance liver echogenicity by accumulating in Kupffer cells, making tumors visible. This ultrasound contrast agent shows promise for detecting liver lesions.
Area of Science:
- Medical Imaging
- Biomedical Engineering
- Pharmacology
Background:
- Iodipimide ethyl ester (IDE) forms dense, spherical particles with a narrow diameter distribution.
- Intravenous injection leads to Kupffer cell accumulation in hepatic sinusoids within 10-20 minutes, followed by clearance.
- These particles serve as scattering sites, increasing normal liver tissue echogenicity.
Purpose of the Study:
- To evaluate IDE particles as an ultrasound contrast agent for liver imaging.
- To assess the ability of IDE to differentiate normal liver tissue from tumors.
- To investigate contrast enhancement in rabbit livers with implanted VX2 tumors.
Main Methods:
- In vivo and ex vivo scanning of rabbit livers using pulse-echo techniques.
- Formulation of IDE into dense spherical particles.
- Intravenous injection of IDE particles.
Main Results:
- Normal liver tissue echogenicity increased significantly after IDE particle uptake.
- VX2 tumors remained at pre-injection echogenicity, showing a distinct contrast.
- Observed echogenicity exceeded predictions from single-particle backscatter theory, suggesting lobular distribution effects.
Conclusions:
- IDE particles demonstrate potential as an ultrasound contrast agent for liver lesion detection.
- The differential uptake by Kupffer cells provides a mechanism for contrast enhancement.
- Further research is needed to optimize particle distribution and validate findings.